Suppression of immune responses to β-lactoglobulin in mice by the oral administration of peptides representing dominant T cell epitopes

Journal of the Science of Food and Agriculture

Volumn 88, Issue 3, 2008, Pages 542-549

  Mizumachi, Koko ^a   Tsuji, Noriko M ^b   Kurisaki, Jun Ichi ^c  

^a NATIONAL INSTITUTE OF LIVESTOCK AND GRASSLAND SCIENCE   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c JUMONJI UNIVERSITY   (Japan)

Author keywords

lactoglobulin; Milk allergy; Oral tolerance; Peptide; T cell epitope

Indexed keywords

BOVINAE; MURINAE; MUS;

EID: 38749114683     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.3122     Document Type: Article

References (30)

1. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P and Isolauri E, Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076-1079 (2001).
2. Rautava S, Kalliomaki M and Isolauri E. New therapeutic strategy for combating the increasing burden of allergic disease: probiotics - a Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin Immunol 116:31-37 (2005).
3. Mowat AM, The regulation of immune responses to dietary antigens. Immunol Today 8:93-98 (1987).
4. Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, et al., Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann Rev Immunol 12:809-837 (1994).
5. Hoyne GF, Callow MG, Kuo MC and Thomas WR, Inhibition of T-cell responses by feeding peptides containing major and cryptic epitopes: studies with the Der p I allergen. Immunology 83:190-195 (1994).
6. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10:1969-1980 (1998).
7. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, et al., Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727-1730 (1993).
8. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, et al., Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321-1324 (1993).
9. Baggi F, Andreetta F, Caspani E, Milani M, Longhi R, Mantegazza R, et al., Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis. J Clin Invest 104:1287-1295 (1999).
10. Gregerson DS, Obritsch WF and Donoso LA, Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 151:5751-5761 (1993).
11. Miller A, al-Sabbagh A, Santos LM, Das MP and Weiner HL, Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 151:7307-7315 (1993).
12. Weiner HL, Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335-343 (1997).
13. Takagi H, Hiroi T, Yang L, Tada Y, Yuki Y, Takamura K, et al., A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci USA 102:17525-17530 (2005).
14. Tsuji NM, Kurisaki J, Mizumachi K and Kaminogawa S, Localization of T-cell determinants on bovine β-lactoglobulin. Immunol Lett 37:215-221 (1993).
15. Aschaffenburg R and Drewry J, Improved method for the preparation of crystalline β-lactoglobulin and α-lactoalbumin from cow's milk. Biochem J 65:273-277 (1957).
16. Friedman A and Weiner HL, Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91:6688-6692 (1994).
17. Whitacre CC, Gienapp IE, Orosz CG and Bitar DM, Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 147:2155-2163 (1991).
18. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK and Weiner HL, Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177-180 (1995).
19. Chen Y, Kuchroo VK, Inobe J, Hafler DA and Weiner HL, Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237-1240 (1994).
20. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742 (1997).
21. Weiner HL, Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol Rev 182:207-214 (2001).
22. + T cell responses to a self peptide. Eur J Immunol 30:136-144 (2000).
23. Taams LS, van Rensen AJ, Poelen MC, van Els CA, Besseling AC, Wagenaar JP, et al., Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur J Immunol 28:2902-2912 (1998).
24. + immunoregulatory T cells is antigen nonspecific. J Immunol 164:183-190 (2000).
25. + T cells and protection in airway allergy models. Vaccine 23:3181-3186 (2005).
26. Tsuji NM, Mizumachi K and Kurisaki J, Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance. Immunology 103:458-464 (2001).
27. + regulatory T cell clones induced in Peyer's patches. Int Immunol 15:525-534 (2003).
28. Cibotti R, Kanellopoulos JM, Pabaniols CJ, Halle-Panenko O, Kosmatopoulos K, Sercarz E, et al., Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc Natl Acad Sci USA 89:416-420 (1992).
29. Evavold BD and Allen PM, Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308-1310 (1991).
30. Pecquet S, Bovetto L, Maynard F and Fritsche R, Peptides obtained by tryptic hydrolysis of bovine β-lactoglobulin induce specific oral tolerance in mice. J Allergy Clin Immunol 105:514-521 (2000).